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Abstract: The cytokine profile during acute chikungunya infection that predicts future chronic
arthritis has not yet been investigated. We conducted a nested case-control study comparing serum
cytokine concentrations during acute chikungunya infection in cases (n = 121) that reported the
presence of chronic joint pain versus age- and gender-matched controls (n = 121) who reported
recovery at 20 months post infection. We observed that a robust cytokine response during acute
infection was correlated with a decreased incidence of chronic joint pain and that low TNFα, IL-13,
IL-2, and IL-4 during acute infection was predictive of chronic joint pain. These data suggest that a
robust cytokine response is necessary for viral clearance and cytokines that are related to immune
tolerance during acute infection may be protective for chronic arthritis pathogenesis.
Keywords: arthritis; chikungunya; cytokine; alphavirus
1. Introduction
Chikungunya virus (CHIKV) is an alphavirus that is spread by mosquitos, infects an estimated
1 million people annually [1], and causes a chronic debilitating arthritis in one fourth of infected
individuals [2]. CHIKV-induced arthritis is associated with a high initial viral load and prolonged
viral infection [3], suggesting that the joint symptoms may result from either failure of the innate
immune system to clear the virus or post-viral, immune-mediated inflammatory responses. Since the
mechanism of CHIKV chronic arthritis pathogenesis is not well-established, there is no standard
treatment for this debilitating condition.
To better understand the immune factors during acute CHIKV infection that contribute to
chronic arthritis pathogenesis, we conducted a nested case-control study comparing serum cytokine
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concentrations during acute chikungunya infection in cases (n = 121) that reported the presence
of chronic joint pain versus age- and gender-matched controls (n = 121) who reported recovery at
20 months post infection. Our hypothesis was that CHIKV cases with higher levels of cytokines
that mediate acute inflammation (IL-6, IL-1β, TNF-α) or stimulate humoral (IL-5) or cellular (IL-12)
inflammation during acute infection would be more likely develop chronic joint pain. Interestingly,
we observed that a robust cytokine response during acute infection was correlated with a decreased
incidence of chronic joint pain and, specifically, that low TNFα, IL-13, IL-2, and IL-4 during acute
infection was predictive of chronic joint pain.
2. Materials and Methods
2.1. Study Design
As previously reported [2], 500 patients with clinically confirmed chikungunya virus infection
were enrolled as part of a prospective cohort in January 2015. Briefly, a diagnosis of chikungunya virus
was serologically confirmed via IgM and IgG antibody capture enzyme-linked immunosorbent assay
(ELISA). A baseline 33-item survey was conducted to ascertain demographic characteristics, exposure
history, and symptoms. A subsequent 56-item telephone survey was performed a median of 20 months
after infection and included an assessment of the character and duration of persistent chikungunya
arthritis symptoms.
For this nested case-control analysis, we matched each case that reported chronic arthritis that
was attributed to their CHIKV infection at a median of 20 months post infection with an age- and
gender-matched CHIKV control patient without chronic arthritis at the same timepoint. Serum
cytokine concentrations during acute infection were compared in cases versus controls.
2.2. Ethics Statement
All subjects gave their informed consent for inclusion before they participated in the study.
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by the Ethics Committee of Universidad El Bosque (Protocol: Vigilancia centinela de eventos
infecciosos en Colombia).
2.3. Setting
The patients were referred to the study from the Sabanalarga, Barranquilla, Juan de Acosta,
Manatí, Luruaco, and Baranoa municipalities in the Atlántico Department, Colombia.
2.4. Participants
Patients with clinical symptoms of chikungunya with a fever of >38 ◦C, severe joint pain or
arthritis, and acute onset of erythema multiforme, with symptoms not explained by other medical
conditions, and serologic confirmation of CHIKV infection were included.
2.5. Serum Cytokine Evaluation
Sera were stored at −80 ◦C until analysis. Evaluation of the serum cytokine concentration of
interleukin (IL)-10, IL-1β, IL-6, tumor necrosis factor (TNF)-α, IL-12 (p70), IL-13, IL-17, IL-2, IL-4,
and IL-5 was performed using the MilliplexR MAP Kit High Sensitivity Magnetic Bead Panel on a
MAGPIXR powered by LuminexR XMAP technology.
2.6. Statistical Analysis
Cytokine distributions were examined with histograms and all were highly positively skewed,
often with outliers. p-values for the Shapiro–Wilks test of non-normality, QQ plots, and the mean and
standard deviation versus median and interquartile range were examined. The QQ plot for normally
distributed variables shows that the data points were aligned in a linear arrangement (age plot),
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while the shape becomes either S-shaped or J-shaped when there is non-normality and/or outliers as
shown in the graphs. The Kruskal–Wallis test was used to test for differences in the distribution location
(median) for patients with versus without joint pain, for each cytokine. Each cytokine was significantly
non-normal (all p < 0.0001). We therefore coded each cytokine level into quintiles. The association
of a cytokine quintile with joint pain was examined with a chi-square test and graphed. Spearman
correlations between cytokine levels were examined. To understand which cytokines had independent
associations with joint pain, we used a multivariable logistic regression model, also including age and
sex as covariates. Stepwise selection was used with p < 0.20 required for model entry and exit. Based on
the final model, we calculated each subject’s probability of having joint pain using the logistic model.
The probability values were coded into quintiles, and the association of the probability quintiles with
joint pain was examined with a chi-square test. Statistical analyses were conducted using SAS software,
version 9.4 (SAS Institute Inc., Cary, NC, USA).
3. Results
The serum cytokine levels (Supplemental Table S1) of age- and gender-matched patients with
(n = 121) and without (n = 121) chronic arthritis 20 months post infection were compared (Table 1
Patient Characteristics). All of the cytokines were detected in all of the patients. Distribution statistics
are shown in Supplemental Table 1, and the frequency histograms and QQ plots for each cytokine
are shown in Supplemental Figure 1. Statistics and graphs for age are also shown as a comparison,
since this variable was normally distributed. In general, mean levels were 2 to 4 times higher in
those patients without joint pain, and median levels were generally 50% to 100% higher (all p < 0.0001)
(Supplemental Table S2). In each graph, with increasing cytokine quintile, the number of patients who
are positive for joint pain decreases, while the number who are negative for joint pain increases
(Supplemental Table S2). Each cytokine was significantly negatively associated with joint pain
(all p < 0.0001) (Figure 1). Spearman r’s in general were in the range of 0.40 to 0.75 and all were
significant (all p < 0.0001). None of the Spearman r’s between any cytokines and age or sex were
significant. Spearman r’s between cytokines and joint pain were all significant (all p < 0.0001) and
ranged from −0.57 (for IL-4) and −0.55 (for IL-2) to −0.41 (for IL-1β) and −0.34 (for IL-6).
Table 1. Patient characteristics 20 months post chikungunya infection.
Patient Characteristic With Joint Pain(n = 121)
Without Joint Pain
(n = 121)
Age, mean ± (SD) in years 49 ± 17 48 ± 17
Female, percent 89% 89%
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Figure 1. Association of cytokine quintiles with joint pain.
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The logistic regression model had an area under the curve (AUC) of 0.88, and the final
model included TNFα, IL-13, IL-2, and IL-4 (Table 2). Calibration was excellent, with very strong
correspondence between the predicted probability and the observed incidence of joint pain, across risk
quintiles (Figure 2). In the examination of cytokine patterns, for the purpose of allowing for the best
differentiation of cytokine patterns, we do not include the other cytokines, which are more weakly
associated with joint pain. What we found is that the patterns themselves are similar between patients
with versus without joint pain; however, those with joint pain simply have lower baseline levels across
all of the cytokines (Supplemental Figure S3).
Table 2. The final logistic regression model for cytokines.
Cytokine Quintile Adjusted OR 95% Wald Confidence Limits p Parameter Estimate (se)
TNFα 0.650 0.487 0.866 0.0033 −0.43 (0.15)
IL-13 0.799 0.567 1.125 0.1984 −0.22 (0.17)
IL-2 0.573 0.401 0.819 0.0023 −0.56 (0.18)
IL-4 0.504 0.372 0.683 <0.0001 −0.68 (0.15)
Intercept <0.0001 3.66
Associations with joint pain. The equation to calculate the probability of having joint pain was risk = 3.66,
–0.43(TNFα), –0.22(IL-13), –0.56(IL-2), –0.68(IL-4), where the quintile (scored 0–4) is used for each cytokine.
Probability = exp(risk)/(1 + exp(risk)). OR, odds ratio.
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Figure 2. Calibration of the logistic regression model’s risk scores versus incidence of joint pain. There
is very strong correspondence between the predicted probability and the observed incidence of joint
pain across risk quintiles.
4. Discussion
This is the largest age- and gender-matched analysis to report that the cytokine profile is predictive
of chronic arthritis after CHIKV infection. We observed that a robust cytokine response during acute
infection was correlated with a decreased incidence of chronic joint pain and that lower TNFα, IL-2,
IL-4, and IL-13 during acute infection was predictive of chronic joint pain. These data suggest that a
robust cytokine response is necessary for viral clearance; in particular, TNFα and cytokines that are
related to immune tolerance during acute infection may be protective for chronic arthritis pathogenesis.
The available studies have reported similar results, suggesting that chronic arthritis is associated
with deregulation of inflammation during acute and convalescent phases, with decreases in Th2
cytokines and increases in Th1 cytokines in those with persistent symptoms [3–6]. Our findings are
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also consistent with findings from Hoarau et al., who found that the Th2 cytokines IL-4 and IL-13
tended to be produced in smaller amounts during the acute phase in patients progressing to chronic
disease; however, their comparisons were not statistically significant, perhaps due to the small sample
size of 15 people [3].
We also found that IL-2 was decreased during acute infection in patients progressing to chronic
disease. This may be of importance, as IL-2 is known to prevent autoimmune disease by promoting
the differentiation of naïve T cells into regulatory T cells [7]. CHIKV arthritis is characterized by
an infiltration of large numbers of CD4+ T cells into the joint tissue [3], and CD4+ T cells are known
to be important in CHIKV joint swelling [8] and chronic joint pain (3). Failure of cell-mediated
immune tolerance may contribute to CHIKV arthritis pathogenesis. Recombinant IL-2, aldesleukin,
has been approved for the treatment of cancers [9] and has been successful in the immune modulation
of autoimmune diseases, such as type 1 diabetes and vasculitis [10]. Further research is needed to
determine the implications for cytokine treatments in CHIKV arthritis.
One limitation of this analysis is that, given the case-control design with fifty percent prevalence
of joint pain, this mathematical model may not necessarily be clinically useful to predict the incidence
of chronic joint pain in populations with a lower prevalence of joint pain. The primary value
of this analysis is to provide insights into the pathophysiologic mechanisms of chronic CHIKV
arthritis pathogenesis.
Supplementary Materials: The supplementary materials are available online http://www.mdpi.com/2079-9721/
6/4/95/s1.
Author Contributions: Conceptualization, A.Y.C., G.F., G.L.S. and J.M.B.; Methodology, A.Y.C., S.T., S.P.R., K.M.,
L.E., N.P., R.L.A., A.P.R., A.R.M., G.L., J.P., G.L.S. and J.M.B.; Validation, A.Y.C., S.T., R.L.A., G.L., J.P. and J.M.B.;
Formal Analysis, A.Y.C., S.T., R.L.A., G.L. and J.M.B.; Investigation, A.Y.C., S.T., S.P.R., K.M., L.E., N.P., R.L.A.,
A.P.R., A.R.M., G.L., J.P., G.F., G.L.S. and J.M.B.; Resources, A.Y.C., S.P.R., K.M., L.E., N.P. and J.M.B.; Data Curation,
A.Y.C., S.T., S.P.R., K.M., L.E., N.P., R.L.A., G.L., J.P. and J.M.B.; Writing (Original Draft Preparation), A.Y.C. and
R.L.A.; Writing (Review & Editing), A.Y.C., S.T., S.P.R., K.M., L.E., N.P., R.L.A., A.P.R., A.R.M., G.L., J.P., G.F., G.L.S.
and J.M.B.; Supervision, A.Y.C., G.L.S. and J.M.B.; Funding Acquisition, A.Y.C. and J.M.B.
Funding: This publication was supported by Award Numbers UL1TR001876 and KL2TR001877 from the National
Institutes of Health (NIH) National Center for Advancing Translational Sciences, and the Rheumatology Research
Foundation. Its contents are solely the responsibility of the authors and do not necessary represent the official
views of the National Center for Advancing Translational Science or the NIH.
Acknowledgments: This publication was made possible by the support of multiple institutions, including the
Allied Research Society LLC, Universidad El Bosque, The George Washington University, and the Medical Faculty
Associates (Washington, DC). Specifically, the authors would like to thank Martha Utrera and Ariel Gonzalez for
their support in this project.
Conflicts of Interest: The authors declare no conflict of interest. The funding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the
decision to publish the results.
References
1. Chikungunya: Communicable Diseases and Health Analysis (CHA). Chikungunya: Data, Maps and Statistics.
Available online: https://www.paho.org/hq/index.php?option=com_topics&view=rdmore&cid=5927&
item=chikungunya&type=statistics&Itemid=40931&lang=en (accessed on 22 December 2017).
2. Chang, A.Y.; Encinales, L.; Porras, A.; Pacheco, N.; Reid, S.P.; Martins, K.A.O.; Pacheco, S.; Bravo, E.;
Navarno, M.; Rico Mendoza, A.; et al. Frequency of Chronic Joint Pain Following Chikungunya Virus
Infection. Arthritis Rheumatol. 2018, 70, 578–584. [CrossRef] [PubMed]
3. Hoarau, J.J.; Jaffar Bandjee, M.C.; Krejbich Trotot, P.; Das, T.; Li-Pat-Yuen, G.; Dassa, B.; Denizot, M.;
Guichard, E.; Ribera, A.; Henni, T.; et al. Persistent chronic inflammation and infection by Chikungunya
arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 2010, 184, 5914–5927.
[CrossRef] [PubMed]
4. Kelvin, A.A.; Banner, D.; Silvi, G.; Moro, M.L.; Spataro, N.; Gaibani, P.; Cavrini, F.; Pierro, A.; Rossini, G.;
Cameron, M.J.; et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and
symptom severity. PLoS Negl. Trop. Dis. 2011, 5, e1279. [CrossRef] [PubMed]
Diseases 2018, 6, 95 7 of 7
5. Chaaitanya, I.K.; Muruganandam, N.; Sundaram, S.G.; Kawalekar, O.; Sugunan, A.P.; Manimunda, S.P.;
Ghosal, S.R.; Muthumani, K.; Vijayachari, P. Role of proinflammatory cytokines and chemokines in chronic
arthropathy in CHIKV infection. Viral Immunol. 2011, 24, 265–271. [CrossRef] [PubMed]
6. Chow, A.; Her, Z.; Ong, E.K.; Chen, J.M.; Dimatatac, F.; Kwek, D.J.; Barkham, T.; Yang, H.; Rénia, L.; Leo, Y.S.;
et al. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and
granulocyte macrophage colony-stimulating factor. J. Infect. Dis. 2011, 203, 149–157. [CrossRef] [PubMed]
7. Liao, W.; Lin, J.X.; Leonard, W.J. IL-2 family cytokines: New insights into the complex roles of IL-2 as a broad
regulator of T helper cell differentiation. Curr. Opin. Immunol. 2011, 23, 598–604. [CrossRef] [PubMed]
8. Teo, T.H.; Lum, F.M.; Claser, C.; Lulla, V.; Lulla, A.; Merits, A.; Rénia, L.; Ng, L.F. A Pathogenic Role for CD4+
T Cells during Chikungunya Virus Infection in Mice. J. Immunol. 2013, 190, 259–269. [CrossRef] [PubMed]
9. Noble, S.; Goa, K.L. Aldesleukin (recombinant interleukin-2). BioDrugs 1997, 7, 394–422. [CrossRef] [PubMed]
10. Hartemann, A.; Bensimon, G.; Payan, C.A.; Jacqueminet, S.; Bourron, O.; Nicolas, N.; Fonfrede, M.;
Rosenzwajg, M.; Bernard, C.; Klatzmann, D. Low-dose interleukin 2 in patients with type 1 diabetes:
A phase 1/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2013, 1, 295–305.
[CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
